间质性肺病对类风湿关节炎临床缓解及不良事件的影响:IORRA队列研究结果
基于IORRA队列2011至2012年基线未达DAS28缓解且行胸部CT的类风湿关节炎患者,分为间质性肺病组287例与非间质性肺病组1235例。间质性肺病组5年内至少一次达DAS28缓解的比例为55.7%,低于非间质性肺病组的75.0%,且与未达缓解、死亡、住院感染、主要不良心血管事件及肺癌显著相关。
要点
- 间质性肺病组5年内至少一次DAS28缓解的比例为55.7%,非间质性肺病组为75.0%。
- 间质性肺病与未达DAS28缓解显著相关(aHR 0.71;95%CI 0.58, 0.89)。
- 间质性肺病与死亡、住院感染、主要不良心血管事件及肺癌显著相关,与恶性淋巴瘤无显著相关。
核心结论
- 合并间质性肺病是类风湿关节炎患者未达临床缓解及发生不良临床事件(死亡、住院感染、主要不良心血管事件、肺癌)的显著相关因素。
研究设计与样本
- 研究纳入IORRA队列2011至2012年基线未达DAS28缓解且具有胸部CT图像的类风湿关节炎患者,依据胸部CT分为间质性肺病组287例与非间质性肺病组1235例。
- 采用时间依赖Cox回归模型评估间质性肺病与5年内达DAS28缓解时间及死亡、住院感染、主要不良心血管事件、恶性肿瘤发生之间的关联。
主要发现
- 间质性肺病组5年内至少一次达DAS28缓解的比例为55.7%,非间质性肺病组为75.0%。
- 间质性肺病与未达DAS28缓解显著相关(aHR 0.71;95%CI 0.58, 0.89)。
- 间质性肺病与死亡显著相关(aHR 3.24;95%CI 2.08, 5.03)。
- 间质性肺病与住院感染(aHR 2.60;95%CI 1.77, 3.83)、主要不良心血管事件(aHR 3.40;95%CI 1.76, 6.58)及肺癌(aHR 16.0;95%CI 3.22, 79.2)显著相关,与恶性淋巴瘤无显著相关(aHR 2.27;95%CI 0.59, 8.81)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to examine the impact of concomitant interstitial lung disease (ILD) on achieving clinical remission and the occurrence of unfavourable clinical events in patients with RA. METHODS: Among the participants in the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) cohort from 2011 to 2012, patients not achieving remission of 28-joint disease activity score (DAS28) at baseline and those with chest CT images were enrolled. Based on the chest CT images, the patients were divided into two groups: the ILD group and non-ILD group. The associations among the presence of ILD with time to achieving DAS28 remission and development of death, hospitalized infection, major adverse cardiac events (MACE), or malignancy within 5 years were evaluated using time-dependent Cox regression models. RESULTS: We enrolled 287 patients in the ILD group and 1235 in the non-ILD group. DAS28 remission was achieved at least once in 55.7% and 75.0% of the ILD and non-ILD groups within 5 years, respectively. Presence of ILD was significantly associated with failure to achieve DAS28 remission (adjusted hazard ratio [aHR]: 0.71; 95% CI: 0.58, 0.89). ILD was also a significant factor associated with death (aHR: 3.24; 95% CI: 2.08, 5.03), hospitalized infection (aHR 2.60; 95% CI: 1.77, 3.83), MACE (aHR: 3.40; 95% CI: 1.76, 6.58), and lung cancer (aHR: 16.0; 95% CI: 3.22, 79.2), but not with malignant lymphoma (aHR: 2.27; 95% CI: 0.59, 8.81). CONCLUSION: Concomitant ILD was a significant factor associated with failure to achieve clinical remission and the occurrence of the unfavourable clinical events in patients with RA.
引用
- Sugano E, Tanaka E, Inoue E, et al. Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort. Rheumatology (Oxford). 2024. PMID: 37379132. doi:10.1093/rheumatology/kead317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。